Only logged in customers who have purchased this product may leave a review.
New BMK Powder CAS 5449-12-7 Glycidic Acid (Soldium salt) stable supplier
Animal Medicines & Health Care, Veterinary DrugsContact Seller for Price
Shipping is chargablePharmaceutical Intermediate Key intermediate in drug R&D and production, particularly for anti-inflammatory, analgesic, or anticancer agents.
Organic Synthesis Used as a precursor for synthesizing esters, amides, and other derivatives via epoxide ring-opening reactions.
Drug Development Explored for its potential in treating cancers, neurodegenerative diseases, and as a drug carrier.
Biochemical Research Studied for antimicrobial and anti-inflammatory activities in experimental models.
Contact me if you are in any needs
++
Whatsapp/Telegram: +852 96607565
Email: lz3982075@gmail.com
1. Threema: JFD2RNS8
2. Signal: 852 96607565
3. Telegram: @Corazhang
Other Hot Sale CAS:
CAS: 5449-12-7,
CAS: 28578-16-7,
CAS: 49851-31-2,
CAS: 1451-82-7,
Free shipping on orders over $10000!
- No-Risk Money Back Guarantee!
- No Hassle Refunds
- Secure Payments
Reviews (0)
Vendor Info
Vendor Information
- No ratings found yet!
More Products
-
Express Checkout
Cas 1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price -
Express Checkout
Cas1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price -
Express Checkout
CAS 1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price -
Express Checkout
CAS1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price -
Express Checkout
1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price -
Express Checkout
cas 1451-82-7 2b4m 2-bromo-4-methylpropiophenone stable supplier
Animal Medicines & Health Care Contact Seller for Price














Reviews
There are no reviews yet.